Stay updated with breaking news from Topical Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.
The new guidelines updated the AAD's 2016 guidelines and included 18 recommendations and five good practice statements.
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.
Researchers say the novel once-weekly application could improve patient adherence.